Literature DB >> 33609106

Timing of rituximab and immunoglobulin level influence the risk of death for COVID-19 in ANCA-associated vasculitis.

Luca Quartuccio1, Elena Treppo1, Marco Binutti1, Giulia Del Frate1, Salvatore De Vita1.   

Abstract

Entities:  

Year:  2021        PMID： 33609106      PMCID： PMC7928542          DOI： 10.1093/rheumatology/keab175

Source DB:  PubMed          Journal:  Rheumatology (Oxford)        ISSN： 1462-0324            Impact factor:   7.580


× No keyword cloud information.
  5 in total

Review 1.  Protracted severe COVID-19 pneumonia following rituximab treatment: caution needed.

Authors:  Dimitrios Daoussis; Lydia Leonidou; Christina Kalogeropoulou; Fotini Paliogianni; Argyrios Tzouvelekis
Journal:  Rheumatol Int       Date:  2021-08-19       Impact factor: 3.580

2.  Immune thrombotic thrombocytopenic purpura: Personalized therapy using ADAMTS-13 activity and autoantibodies.

Authors:  Francesca Palandri; Christian Di Pietro; Francesca Ricci; Pier Luigi Tazzari; Vanda Randi; Daniela Bartoletti; Michele Cavo; Nicola Vianelli; Giuseppe Auteri
Journal:  Res Pract Thromb Haemost       Date:  2021-12-09

3.  Impact of the COVID-19 pandemic on uveitis patient care.

Authors:  Alexander F Vu; Shilpa Kodati; Phoebe Lin; Bahram Bodaghi; Parisa Emami-Naeini
Journal:  Br J Ophthalmol       Date:  2022-01-24       Impact factor: 4.638

4.  Safety of Biologic-DMARDs in Rheumatic Musculoskeletal Disorders: A Population-Based Study over the First Two Waves of COVID-19 Outbreak.

Authors:  Arianna Sonaglia; Rosanna Comoretto; Enrico Pasut; Elena Treppo; Giulia Del Frate; Donatella Colatutto; Alen Zabotti; Salvatore De Vita; Luca Quartuccio
Journal:  Viruses       Date:  2022-07-01       Impact factor: 5.818

5.  SARS-CoV-2 vaccination in rituximab-treated patients: B cells promote humoral immune responses in the presence of T-cell-mediated immunity.

Authors:  Daniel Mrak; Selma Tobudic; Maximilian Koblischke; Marianne Graninger; Helga Radner; Daniela Sieghart; Philipp Hofer; Thomas Perkmann; Helmuth Haslacher; Renate Thalhammer; Stefan Winkler; Stephan Blüml; Karin Stiasny; Judith H Aberle; Josef S Smolen; Leonhard X Heinz; Daniel Aletaha; Michael Bonelli
Journal:  Ann Rheum Dis       Date:  2021-07-20       Impact factor: 19.103
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.